Australia markets closed

MOBERG PHARMA AB (MB8.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.4000-0.4000 (-14.29%)
As of 12:43PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
820
0
207
0
0
Cost of revenue
-
-
-
-
0
Gross profit
492
0
207
0
0
Operating expenses
Research development
3,760
3,657
1,177
3,449
3,646
Selling general and administrative
27,176
24,860
21,071
18,508
20,533
Total operating expenses
29,625
27,910
20,724
19,730
21,684
Operating income or loss
-29,133
-27,910
-20,517
-19,730
-21,684
Interest expense
249
260
71
129
1,840
Income before tax
-26,810
-25,420
-19,512
-19,970
-23,501
Income tax expense
-4,250
-4,327
-3,802
-3,748
-4,474
Income from continuing operations
-22,560
-21,093
-15,710
-16,222
-19,027
Net income
-22,560
-21,093
-15,710
7,492
-19,863
Net income available to common shareholders
-22,560
-21,093
-15,710
7,492
-19,863
Basic EPS
-0.80
-1.33
-2.07
1.13
-
Diluted EPS
-0.80
-1.33
-2.07
1.13
-
Basic average shares
15,132
15,872
7,587
6,456
-
Diluted average shares
29,264
35,521
7,752
6,620
-